Tools   Select Another Resource Report Type

http://www.cfmice.org/

Core facility for cystic fibrosis mouse strains. Services include mouse production from current strains and creation of new strains, mouse strain maintenance, tissue acquisition, genotyping and treatment of mice with IACUC approved drugs to test potential therapies. Maintains centralized database that contains breeding history, phenotypes observed and experimental records of various CF mouse strains.

Proper citation: Case Western Reserve University Cystic Fibrosis Mouse Models Core (RRID:SCR_017238) Copy   

•   Source: SciCrunch Registry

https://epigenie.com/epigenetic-tools-and-databases/

Collection of epigenetic data browsers and repositories. Repository of epigenetics tools and databases by EpiGenie team.

Proper citation: Epigenie (RRID:SCR_017494) Copy   

•   Source: SciCrunch Registry

http://grantome.com/grant/NIH/U01-DK099919-04S1

Consortium to design and conduct pilot and feasibility studies of novel therapies to reduce morbidity and mortality for patients treated with maintenance hemodialysis. Data Coordinating Center (DCC) for consortium provides scientific expertise and operational support for pilot studies that will be conducted at HDPSC Participating Clinical Centers. Data Coordinating Center for Hemodialysis Pilot Studies Consortium.

Proper citation: Hemodialysis Pilot Studies Consortium (RRID:SCR_017468) Copy   

•   Source: SciCrunch Registry

http://old.iss.it/gemelli/index.php?lang=1

Portal with information about twins in Italy.

Proper citation: Italian Twin Registry (RRID:SCR_017476) Copy   

•   Source: SciCrunch Registry

https://neuron.yale.edu/neuron/

Software for computational neurophysiology. Simulation environment is used for building and using computational models of neurons and networks of neurons. NEURON Users Group can participate in collaborative development of documentation, tutorials, and software.

Proper citation: NEURON (RRID:SCR_017449) Copy   

•   Source: SciCrunch Registry

http://refgenie.databio.org

Software tool to organize, retrieve, and share genome analysis resources. Reference genome assembly asset manager. In addition to genome indexes, can manage any files related to reference genomes, including sequences and annotation files. Includes command line interface and server application that provides RESTful API, so it is useful for both tool development and analysis.

Proper citation: refgenie (RRID:SCR_017574) Copy   

•   Source: SciCrunch Registry

https://www.daqcord.org/

Software tool for practical self assessment and reporting method for clinical research studies, to capture key information about data acquisition and quality control measures. Linked to dataset so that potential research collaborators can determine if data meets their needs and expectations.

Proper citation: DAQCORD (RRID:SCR_017395) Copy   

•   Source: SciCrunch Registry

https://timothyspringer.org/files/tas/files/biacore3000-instrument.pdf

Biacore 3000 processing unit is an established, label-free system for detailed studies of biomolecular interactions. The system delivers comprehensive characterization of the interaction, answers questions about the rate constants, affinity, specificity, and determines the active concentration of components. The ability to recover and transfer interaction partners directly to MALDI targets for identification and further characterization makes the system highly applicable to fast identification of unknown interactants.

Proper citation: GE: Biacore 3000 Real Time Biomolecular Interaction Analyzer (RRID:SCR_018044) Copy   

•   Source: SciCrunch Registry

https://www2.bri.nrc.ca/ccb/pub/sietraj_main.php

Software tool for binding free energies from Amber-generated MD trajectories. Alternative to MM-PBSA software provided by AMBER distribution. Virtual alanine mutations are also possible. Solvated interaction energies are calculated using parameters that have been fitted to reproduce binding free energies of data set of 99 protein-ligand complexes.

Proper citation: sietraj (RRID:SCR_018021) Copy   

•   Source: SciCrunch Registry

http://www.imperial.ac.uk/research/animallectins

Resource presents information about animal lectins involved in various sugar recognition processes.

Proper citation: genomics resource for animal lectins (RRID:SCR_018122) Copy   

•   Source: SciCrunch Registry

http://folk.uio.no/thoree/FEST/

An R package for simulations and likelihood calculations of pair-wise family relationships using DNA marker data. (entry from Genetic Analysis Software)

Proper citation: R/FEST (RRID:SCR_013347) Copy   

•   Source: SciCrunch Registry

http://www-sequence.stanford.edu/group/candida/

The Stanford Genome Technology Center began a whole genome shotgun sequencing of strain SC5314 of Candida albicans. After reaching its original goal of 1.5X mean coverage of the haploid genome (16Mb) in summer, 1998, Stanford was awarded a supplemental grant to continue sequencing up to a coverage of 10X, performing as much assembly of the sequence as possible, using recognizable genes as nucleation points. Candida albicans is one of the most commonly encountered human pathogens, causing a wide variety of infections ranging from mucosal infections in generally healthy persons to life-threatening systemic infections in individuals with impaired immunity. Oral and esophogeal Candida infections are frequently seen in AIDS patients. Few classes of drugs are effective against these fungal infections, and all of them have limitations with regard to efficacy and side-effects.

Proper citation: Sequencing of Candida Albicans (RRID:SCR_013437) Copy   

•   Source: SciCrunch Registry

http://www.physci.ucla.edu/research/GomezPinilla/

We are interested on the mechanisms by which environmental factors affect neuronal health. We have found that trophic factors endogenous to the brain and spinal cord can be induced by the practice of select behaviors. We have recently reported that physical activity, learning, and nutritional factors control neurotrophins in the brain. These findings opened the exciting possibility that regulation of trophic factors by behavior can be a pivotal mechanism by which specific experiences can impact the structure and function of the CNS. It may account for the improvement of CNS function after trauma provided by rehabilitative therapies. On the contrary, it may explain the decay in function in aging or degenerative diseases following a lack of stimulation. These two avenues provide direction for my research program: 1) How trophic factors induced by activity can help functional recovery following brain and spinal cord trauma. We are using several exercise models to boost the production of trophic factors in the brain and spinal cord. Our goal is to provide critical information to guide the design of behavioral therapies for the reduction of the severity of insult or disease, and to increase CNS function. 2) We are evaluating the effects of lifestyle on trophic factor production, with resulting effects on circuit remodeling, synaptic function, and cognition. We believe that changes in trophic factor as a result of select experiences can affect neuronal health with profound consequences for cognitive function. :lab :

Proper citation: Neurotrophic Lab (RRID:SCR_013572) Copy   

•   Source: SciCrunch Registry

http://orwh.od.nih.gov/cfs.html

THIS RESOURCE IS NO LONGER IN SERVICE, documented on July 16, 2013. This website endeavors to provide information on the Chronic Fatigue Syndrome Working Group (CFSWG) and its programs that is helpful to researchers, health care providers, people with CFS and their families, and the general public. :The mission of the Trans-NIH Working Group for Research on Chronic Fatigue Syndrome is to: :* Stimulate and support research on CFS within the context of the missions of all Institutes, Centers and Offices. :* Collaborate and coordinate the research agendas of all Institutes, Centers and Offices to issue on a regular basis joint Program Announcements or theme related Request for Applications to further interdisciplinary research in CFS. :* Present new knowledge to and facilitate novel theoretical approaches to CFS among NIH scientists. :* Plan and sponsor scientific symposia to foster awareness, provoke new scientific interest, and generate interdisciplinary collaboration on CFS among both the NIH and Academic medical community.

Proper citation: Chronic Fatigue Syndrome (RRID:SCR_013641) Copy   

•   Source: SciCrunch Registry

http://biomaterials.syr.edu/

Welcome to the Syracuse Biomaterials Institute! We are a new, interdisciplinary institute focused on research in biomaterials, smart medical devices, and biological/tissue-engineered constructs. Biomaterials are natural and synthetic substances designed to treat, augment, or replace tissues and organs of the human body as treatments to disease or injury. An outgrowth of the long-standing Biomaterials Group in the Biomedical and Chemical Engineering Department, the Syracuse Biomaterials Institute (SBI) was launched in Fall, 2007, through strategic investments by Syracuse University, New York State Foundation for Science, Technology and Innovation (NYSTAR), and private donations. SBI is a cohesive collection of highly collaborative faculty spanning eight (8) academic units, including faculty from SUNY Upstate Medical University and SUNY College of Environmental Science and Forestry. Our researchers are engaged in a wide spectrum of problems, ranging from fundamental studies of the biochemical and physical processes controlling cell functions to the development of new technologies for biomedical applications. In addition to our collaborative research and teaching activities, we are excited to be designing our future SBI home, planned for Fall 2009, that will collocate our research groups and central laboratory facilities. :jobs board, postdoctoral training program, graduate training program, portal :

Proper citation: Syracuse Biomaterials Institute (RRID:SCR_013626) Copy   

•   Source: SciCrunch Registry

http://www.bmm-program.nl/SITE/PUBLIC/GO/?rid=1

The BioMedical Materials (BMM) consortium focuses on advancing the use of new materials to biomedical research. As a public-private partnership, the consortium includes the participation of over 50 leading institutions, corporations, and health foundations, with support from the government of the Netherlands. The activities of this consortium have ended. The website and materials will be available until 12-31-2015.

Proper citation: BioMedical Materials Consortium (RRID:SCR_013678) Copy   

•   Source: SciCrunch Registry

http://www.ibdbiom.eu/

The Inflammatory Bowel Disease Biomarkers Consortium (IBD-BIOM) addresses the need to improve our understanding of inflammatory bowel disease (IBD) through new biomarkers into molecular dysfunctions that give rise to IBD. The biomarkers targeted by the consortium will be translated into early-detection clinical diagnostic tests for IBD patients.

Proper citation: Inflammatory Bowel Disease Biomarkers Consortium (IBD BIOM) (RRID:SCR_013710) Copy   

•   Source: SciCrunch Registry

http://c-path.org/programs/msoac/

The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) is a public-private partnership which aims to accelerate the development of new therapies for MS by generating new tools for measuring outcomes in clinical trials. It is collecting, standardizing, and analyzing data about MS with the goal of qualifying new measures of disability for the disease. MSOAC is the newest of the eight consortia of Critical Path Institute (C-Path), a nonprofit organization that is dedicated to accelerating drug development by delivering on the mission outlined by FDA''''s critical path initiative.

Proper citation: Multiple Sclerosis Outcome Assessments Consortium (MSOAC) (RRID:SCR_013712) Copy   

•   Source: SciCrunch Registry

http://www.fnih.org/work/research-partners/osteoarthritis-biomarkers-project

The Osteoarthritis Biomarkers Project (OABP) is a consortium designed to identify and classify biological markers of progression of knee osteoarthritis. Their goal is to advance the ability to predict the individual risk of developing severe OA and to monitor progression of OA.

Proper citation: Osteoarthritis Biomarkers Project (OABP) (RRID:SCR_013714) Copy   

•   Source: SciCrunch Registry

https://www.delaneycare.org/index.php

The Collaboratory of AIDS Researchers for Eradication (CARE) is a consortium of scientific experts in the field of HIV latency from several U.S. and European academic research institutions as well as Merck Research Laboratories working together to find a cure for HIV.

Proper citation: Collaboratory of AIDS Researchers for Eradciation (CARE) (RRID:SCR_013681) Copy   

•   Source: SciCrunch Registry